Iron overload and cancer;Surcharge en fer et cancer

Bulletin de l'Academie Nationale de Medecine

Volumn 184, Issue 2, 2000, Pages 355-363

  Blanc, Jean Frédéric ^a   Bioulac Sage, Paullette ^a   Balabaud, Charles ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; HUMAN; IRON OVERLOAD; LIVER CELL CARCINOMA; LIVER TUMOR; REVIEW;

ANIMALS; CARCINOMA, HEPATOCELLULAR; HUMANS; IRON OVERLOAD; LIVER NEOPLASMS;

EID: 0033641385     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. GONZALES J., BENIRCHKE K., SALTMAN P., ROBERTS J., ROBINSON P. - Hemosiderosis in lemurs. Zoo Biol, 1984, 3, 255-65.
2. RANDELL M.G., PATNAIK A.K., GOULD W.J. - Hepatopathy associated with excessive iron storage in Mynah birds. J Am Vet Med Assoc, 1981, 179, 1214-7.
3. ROTHENBERG B.E., VOLAND J.R. - Beta2 knockout mice develop parenchymal iron overload : a putative role for class I genes of the major histocompatibility complex in iron metabolism. Proc Natl Acad Sci U S A, 1996, 93, 1529-34.
4. WEINBERG E.D. - Roles of iron in neoplasia. Promotion, prevention, and therapy. Biol Trace El res, 1992, 34, 123-40.
5. HALLIDAY J.W., SEARLE J. - Hepatic iron deposition in human disease and animal models. Bio Metals, 1996, 9, 205-9.
6. STÅL P., HULTERANTZ R., MOLLER L., ERIKSSON L. - The effects of dietary iron on initiation and promotion in chemical hepatocarcinogenesis. Hepatology, 1995, 21, 521-8.
7. TOYOKUNI S. - Iron-induced carcinogenesis : the role of redox regulation. Free Radic Biol Med, 1996, 20, 553-66.
8. YOUNG I.S., TROUTON T.G., TORNEY J.J., MCMASTER D., CALLENDER M.E., TRIMBLE E.R. -Antioxidant status and lipid peroxidation in hereditary haemochromatosis. Free Radic Biol Med, 1994, 16, 393-7.
9. TOYOKUNI S., MORI T., DIZDAROGLU M. - DNA a base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate. Int J Cancer, 1994, 57, 123-8.
10. ANGHILERI L.J., THOUVENOT P. - Non-transferrin-bound iron and tumor cells. Anticancer Res, 1997, 17, 2529-34.
11. HANN H.W., STAHLHUT M.W., HANN C.L. - Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines. Hepatology, 1990, 11, 566-9.
12. HSIEH-MA S.T., SHI T., REEDER J., RING D.B. - In vitro tumor growth inhibition by bispecific antibodies to human transferrin receptor and tumor-associated antigens is augmented by the iron chelator deferoxamine. Clin Immunol Immunopathol, 1996, 80, 185-93.
13. ZHOU X.D., DE TOLLA L., CUSTER P., LONDON W.T. - Iron, ferritin, hepatitis B surface and core antigens in the livers of chinese patients with hepatocellular carcinoma. Cancer, 1987, 59, 1430-7.
14. DEUGNIER Y.M., CHARALAMBOUS P., LE QUILLEUC D., TURLIN B., SEARLE J., BRISSOT P et al. -Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis : a study of 185 patients. Hepatology, 1993, 18, 1363-9.
15. BROCK J.H. - Iron in infection, immunity, inflammation and neoplasia. In : Brock J., Halliday J., Pippard M., Powell L., editors. Iron metabolism in Health and Disease. London : WB Saunders Company Ltd, 1994, 354-89.
16. GREEN R., ESPARZA I., SCHREIBER R. - Iron inhibits the nonspecific tumoricidal activity of macrophages. A possible contributory mechanism for neoplasia in hemochromatosis. Ann NY Acad Sci, 1988, 526, 301-9.
17. BRISSOT P., HERRY D., VERGER J.P., MESSNER M., REGNOUARD F., FERRAND B. et al. -Assessment of liver iron content in 271 patients : reevaluation of direct and indirect methods. Gastroenterology, 1981, 80, 557-65.
18. SELBY J.V., FRIEDMAN G.D. - Epidemiologic evidence of an association between body iron stores and risk of cancer. Int J Cancer, 1988, 41, 677-82.
19. KNEKT P., REUNAMEN A., TAKKUNEN H., AROMAA A., HELIOVAARA M., HAKULINEN T. - Body iron stores and risk of cancer. Int J Cancer, 1994, 56, 379-82.
20. STEVENS R.G., KUVIBIDILA S., KAPPS M., FRIEDLAENDER J., BLUMBERG B.S. - Iron-binding proteins, hepatitis B virus, and mortality in the Salomon Islands. Am J Epidemiol, 1983, 118, 550-61.
21. NELSON R.L., DAVIS F.G., SUTTER E., SOBIN L.H., KIKENDALL J.W., BOWEN P. - Body iron stores and risk of colonic neoplasia. J Natl Cancer Inst, 1994, 86, 455-60.
22. MANDEL J.S., MCLAUGHLIN J.K., SCHLEHOFER B., MELLEMGAARD A., HELMERT U., LINBLAD P. et al. - International renal-cell cancer study. IV. Occupation. Int J Cancer, 1995, 61, 601-5.
23. ICSO J., SZOLLOSOVA M., SORAHAN T. - Lung cancer among iron ore miners in east Slovakia. Occup Environ Med, 1994, 51, 642-3.
24. HANN H.W., KIM C.Y., LONDON W.T., BLUMBERG B.S. - Increased serum ferritin in chronic liver disease : a risk factor for primary hepatocellular carcinoma. Int J Cancer, 1989, 43, 376-9.
25. FARGION S., FRACANZANI A., PIPERNO A., BRAGA M., D'ALBA R., RONEHI G. et al. -Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis. Hepatology, 1994, 20, 1426-31.
26. DEUGNIER Y., GUYADER D., CRANTOEK L., LOPEZ J.M., TURLIN B., YAOUANQ J. et al. -Primary liver cancer in genetic hemochromatosis : a clinical, pathological and pathogenetic study of 54 cases. Gastroenterology, 1993, 104, 228-34.
27. FELLOWS I.W., STEWART M., JEFFCOATE W.J., SMITH P.G., TOGHILL P.J. - Hepatocellular carcinoma in primary haemochromatosis in the absence of cirrhosis. Gut, 1988, 29, 1603-6.
28. BLUMBERG R.S., CHOPRA S., IBRAHIM R., CRAWFORD J., FARRAYE F.A., SELDIS J.B. et al. -Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal fibrosis. Gastroenterology, 1988, 95, 1399-402.
29. THOMPSON N.P., STANSBY G., JARMULOWICZ M., HOBBS K.E., MCINTYRE N. - Hepatocellular carcinoma arising in non-cirrhotic haemochromatosis. H P B Surgery, 1995, 8, 163-6.
30. TOMAO S., ROMITI A., MOZZICAFREDDO A., RAFFAELE M., ZULLO A., ANTONACI A. - Onset of hepatocellular carcinoma in a non-cirrhotic patient affected with haemochromatosis. Oncol Rep, 1998, 5, 723-5.
31. GOH J., CALLAGY G., MCENTEE G., O'KEANE J.C., BOMFORD A., CROWE J. - Hepatocellular carcinoma arising in the absence of cirrhosis in genetic haemochromatosis : three case reports and review of literature. Eur J Gastroenterol Hepatol, 1999, 11, 915-9.
32. TURLIN B., JUGUET F., MOIRAND R., LE QUILLEUC D., LORÉAL O., CAMPION J-P et al. -Increased liver iron stores in patients with hepatocellular carcinoma developed on a non-cirrhotic liver. Hepatology, 1995, 22, 446-50.
33. GRANDO-LEMAIRE V., GUETTIER C., CHEVRET S., BEAUGRAND M., TRINCHET J.C. - Hepatocellular carcinoma without cirrhosis in the West : epidemiological factors and histopathology of the non-tumorous liver. J Hepatol, 1999, 31, 508-13.
34. BERNARD P.H., BLANC J.F., DE LEDINOHEN V., LE BAIL B., CARLES J. et al. - Carcinome hépatocellulaire sur foie non cirrhotique : facteurs prédictifs de survie. Gastroenterol. clin. biol., 1999, 23 A 176.
35. BLANC J.F., DE LEDINGHEN V., BERNARD P.H., DE VERNEUIL H., WINNOCK M. et al. -Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developped in non-cirrhotic liver. J Hepatol., 2000.
36. MANDISHONA E., MACPHAIL A.P., GORDEUK V.R., KLEDDA M.A., PATERSON A.C., ROUAULT T.A., KEW M.C. - Dietary iron overload as a risk factor for hepatocellular carcinoma in Black Africans. Hepatology, 1998, 27, 1563-6.
37. MOYO V.M., MAKUNIKE R., GANGAIDZO I.T., GORDEUK V.R., MCLAREN C.E., KHUMALO H., SAUNGWEME T., ROUAULT T., KIIRE C.F. - African iron overload and hepatocellular carcinoma (HA-7-0-080). Eur J Haematol, 1998, 60, 28-34.
38. BLANC J.F., DE LEDINGHEN V., TRIMOULET P., LE BAIL B., BERNARD P.H., SARIC J., BALABAUD C., BIOULAC-SAGE - Premalignant lesions and hepatocellular carcinoma in a non-cirrhotic alcoholic patient with iron overload and normal transferrin saturation. J Hepatol, 1999, 30, 325-9.
39. CHEN X., YANG GY, DING W.Y., BONDOC F., CURTIS S.K., YANG C.S. - An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload. Carcinogenesis, 1999, 20, 1801-8.
40. REZAZADEH H., JULKA P.K., ATHAR M. - Iron overload augments 7,12-dimethylbenz(a)anthracene-initiated and 12-O-tetradecanoylphorbol-13-acetate-promoted skin tumorigenesis. Skin Pharmacol Appl Skin Physiol, 1998, Mar-Apr, 11(2), 98-103.